CymaBay Therapeutics, Inc.
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- 2024-02-11
- Valid until
- still holds
- Published
- 2024-02-12
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-09 · its source page states the value and the date
- Confidence
- 0.95
Sources
“On February 11, 2024, Gilead Sciences, Inc., a Delaware corporation (“ Parent ” or “ Gilead ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), among Parent, CymaBay Therapeutics, Inc., a Delaware corporation (the “ Company ”),”— what the page says, read 2026-11-09
Cite this claim
Plain text
AsOf. "Gilead Sciences agreement: CymaBay Therapeutics, Inc.", as of 2024-02-11. Claim clm_BEFBDF4F70C1, https://asof.is/claim/clm_BEFBDF4F70C1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/882095/000095010324002027/0000950103-24-002027-index.htm.
APA
AsOf. (2024). Gilead Sciences agreement: CymaBay Therapeutics, Inc. (as of 2024-02-11) [Record clm_BEFBDF4F70C1]. Retrieved November 10, 2026, from https://asof.is/claim/clm_BEFBDF4F70C1 (source: https://www.sec.gov/Archives/edgar/data/882095/000095010324002027/0000950103-24-002027-index.htm)
BibTeX
@misc{asof_clm_BEFBDF4F70C1,
author = {AsOf},
title = {Gilead Sciences agreement: CymaBay Therapeutics, Inc.},
year = {2024},
howpublished = {\url{https://asof.is/claim/clm_BEFBDF4F70C1}},
note = {Claim clm\_BEFBDF4F70C1, as of 2024-02-11; source: https://www.sec.gov/Archives/edgar/data/882095/000095010324002027/0000950103-24-002027-index.htm},
urldate = {2026-11-10}
}On the record
/claim/clm_BEFBDF4F70C1.md/v1/claims/clm_BEFBDF4F70C1submit a correction